Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azadeh Feizpour

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
JAMA Neurology|September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer DiseaseGemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathologyRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging|March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Neuroscience|July 16, 2025
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sexRik Ossenkoppele, Emma M Coomans, Liana G Apostolova, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
JAMA Neurology|September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer DiseaseGemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathologyRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging|March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Neuroscience|July 16, 2025
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sexRik Ossenkoppele, Emma M Coomans, Liana G Apostolova, et al.
Pageof 4